Compare Becton Dickinson and Co (BDX) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance

Becton Dickinson and CoTrade

Invesco NASDAQ 100 ETFTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Invesco NASDAQ 100 ETF — how do they compare? Becton Dickinson and Co trades at $182.47 (market cap $49.41B), while Invesco NASDAQ 100 ETF trades at $298.39. The key difference: Becton Dickinson and Co pays a 2.32% dividend while Invesco NASDAQ 100 ETF pays none. Which is the better fit depends on your goals.

	BDX	QQQM
Market Cap	$49.41B	—
Sector	Health	Broad Market / Factor
52-Week High	$185.39	$307.23
52-Week Low	$138.62	$229.87
Enterprise Value	$65.51B	—
Dividend Yield	2.32%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

BDX trades at $180.64, up 0.56% today, near its consensus price target of $183. The stock shows bullish technical signals with strong moving averages and recent earnings beats in Q2 2026. Revenue growth is steady, with Q3 2026 reaching $5 billion, though margins face pressure from tariffs. The company maintains a Dividend Aristocrat status with consistent payouts.

Outlook is cautiously optimistic with analyst consensus leaning buy, but risks include margin compression and debt levels. The stock offers stability through dividends and sector resilience, yet investors should monitor earnings sustainability and competitive threats in the medical technology space.

Invesco NASDAQ 100 ETF

QQQM, tracking the Nasdaq-100, trades at $298.55, up 0.59% with a bullish technical signal from moving averages. The ETF benefits from lower fees compared to QQQ, attracting cost-conscious investors. Recent news highlights its inclusion in retirement portfolios and strong inflows into Nasdaq-focused ETFs, supported by tech sector performance.

Outlook remains positive due to tech-led growth, but risks include market volatility and concentration in mega-cap stocks. The ETF offers exposure to high-growth companies, with institutional activity showing mixed signals, such as Bank of America reducing its position in Q2 2026.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BDX

BD completes enrollment in large trial testing Phasix™ Mesh to prevent incisional hernias after surgeryPRNewsWire · 12 hours agoBullish Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral View details →

QQQM

JEPQ’s high yield comes with costly ordinary income taxes and capped gains, hurting taxable investors.24/7 Wall Street · 1 day agoBearish Invesco QQQ ETF costs more than its cheaper clone QQQM despite identical holdings.24/7 Wall Street · 2 days agoNeutral View details →

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

About Invesco NASDAQ 100 ETF

QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.